2,5-Dimethoxy-4-trifluoromethylamphetamine

2,5-Dimethoxy-4-trifluoromethylamphetamine
Systematic (IUPAC) name
(RS)-1-[2,5-dimethoxy-4-(trifluoromethyl)phenyl]propan-2-amine
Clinical data
Pregnancy cat.  ?
Legal status Uncontrolled
Identifiers
ATC code  ?
PubChem CID 10400521
ChemSpider 8575959 Y
ChEMBL CHEMBL6620 Y
Synonyms 2,5-dimethoxy-4-trifluoromethylamphetamine
Chemical data
Formula C12H16F3NO2
Mol. mass 263.26 g/mol
SMILES eMolecules & PubChem
 Y(what is this?)  (verify)

2,5-Dimethoxy-4-trifluoromethylamphetamine (DOTFM) is a psychedelic drug of the phenethylamine and amphetamine chemical classes. It was first synthesized in 1994 by a team at Purdue University led by David E. Nichols.[1] DOTFM is the alpha-methylated analogue of 2C-TFM, and is around twice as potent in animal studies. It acts as an agonist at the 5HT2A and 5HT2C receptors. In drug-substitution experiments in rats, DOTFM fully substituted for LSD and was slightly more potent than DOI.[1] Anecdotal reports from human users suggest that DOTFM is a potent psychedelic with an extremely long duration of action, similar to Br-DFLY.

See also

References

  1. ^ a b Nichols DE, Frescas S, Marona-Lewicka D, et al. (December 1994). "1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist". Journal of Medicinal Chemistry 37 (25): 4346–51. doi:10.1021/jm00051a011. PMID 7996545.